Table 1 Final pathological diagnosis of 453 adnexal masses
From: Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses
Pathologic diagnosis | No.(%) |
|---|---|
Benign adnexal masses | 184 (40.62) |
 Mature teratoma | 71 (15.67) |
 Mucinous cystadenoma | 49 (10.82) |
 Serous cystadenoma | 31 (6.84) |
 Thecoma fibroma | 8 (1.77) |
 Struma ovarii | 6 (1.32) |
 Thecoma of the ovary | 5 (1.10) |
 Fibroma | 4 (0.88) |
 Serous adenofibroma | 2 (0.44) |
 Brenner tumor | 2 (0.44) |
 Endometrioid cyst | 2 (0.44) |
 Microcystic stromal tumor | 1 (0.22) |
 Wolffian tumor | 1 (0.22) |
 Inclusion cyst | 1 (0.22) |
 Mucinous adenofibroma | 1 (0.22) |
Malignant adnexal masses | 269 (59.38) |
 Serous cystadenocarcinoma | 158 (34.88) |
 Borderline mucinous cystadenoma | 28 (6.18) |
 Borderline serous cystadenoma | 20 (4.42) |
 Clear cell carcinoma | 15 (3.31) |
 Metastatic carcinoma | 13 (2.87) |
 Endometrioid carcinoma | 6 (1.32) |
 Malignant Mullerian tube mixed tumor | 5 (1.10) |
 Granular cell tumor | 4 (0.88) |
 Mixed carcinoma | 4 (0.88) |
 Mucinous cystadenocarcinoma | 3 (0.66) |
 Ovarian dysgerminoma | 2 (0.44) |
 Sertoli-Leydig cell tumor | 2 (0.44) |
 Endometrioid borderline tumor | 2 (0.44) |
 Yolk sac tumor | 2 (0.44) |
 Immature teratoma | 2 (0.44) |
 Adult granulose cell tumor of the ovary | 1 (0.22) |
 Borderline Brenner Tumor | 1 (0.22) |
 Small cell carcinoma of the ovary-hypercalcemic type | 1 (0.22) |